US · Healthcare · Health Information Services
EPS came in at 0.19 against a street estimate of 0.25 — a miss of 24.0%.
Analysts rate Privia Health Group Inc a strong buy (19 buy, 2 hold, 0 sell out of 21) with an average price target of $31.89.
| Fund | Stake |
|---|---|
| BlackRock Inc | 15.12% |
| FMR Inc | 10.35% |
| Durable Capital Partners LP | 9.59% |
| Van Berkom and Associates Inc | 6.43% |
| Vanguard Portfolio Management, LLC | 4.98% |
| Rubicon Founders LLC | 4.72% |
| Vanguard Capital Management, LLC | 3.97% |
| State Street Corp | 3.56% |
| Document | Date |
|---|---|
| Board / officer change · Q3 2026 | 2026-07-07 |
| Shareholder vote results · Q2 2026 | 2026-05-22 |
| Quarterly report · Q1 2026 | 2026-05-07 |
| Results announced · Q2 2026 | 2026-05-07 |
| Proxy statement · Q2 2026 | 2026-04-02 |
| Annual report FY2025 | 2026-02-27 |
| Results announced · Q1 2026 | 2026-02-26 |
| Quarterly report · Q3 2025 | 2025-11-06 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Privia Health Group Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.